Clinical Trial Update: Precision Rifampin Trial for Personalized Dosing [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from the University of Virginia is evaluating precision, personalized dosing of rifampin for tuberculosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: University of Virginia | Conditions: Tuberculosis | Phase 1 | Status: RECRUITING